The UK MHRA has released details of a consultation to provide ongoing cost recovery.
Returning from a long holiday and need to catch up on EU medical device and IVD regulatory developments? Read our update on European regulatory news over the last few months.
Schedule a meeting with us to learn more about how we can support your regulatory needs so that you can get to market faster.
The FDA issued the Final Rule (FR Doc. 2024-18983) and Final Guidance on the Electronic Submission Template for De Novo (FDA-2023-D-3788) on August 23, 2024. Within the final guidance, the FDA announced that eSTAR would be compulsory for De Novos, beginning October 1, 2025.
Thailand’s medical device regulator has released the list of regulators and agencies it will accept. The list includes the former Global Harmonization Task Force (GHTF) founding members the World Health Organization (WHO), and the Singapore Health Sciences Authority (HSA).
In its August 22 webinar, the U.S. Food and Drug Administration (FDA) discussed the Stage 1 requirements imposed on laboratory-developed test (LDT) manufacturers.
The Hong Kong Department of Health has delayed release timelines for multiple new Medical Device Information System (MDIS) features to September 2024, including electronic submissions for adverse event and safety alert reports.
Meet with our experts to discover how we can support you in navigating complex medical device regulatory landscapes.
This white paper discusses the basics of South Korea’s Unique Device Identifier (UDI) regulation and recommends steps for implementing a UDI system.